Annual Operating Profit
-$131.99 M
-$36.91 M-38.81%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual operating income is -$131.99 million, with the most recent change of -$36.91 million (-38.81%) on April 30, 2024.
- During the last 3 years, KALV annual operating profit has fallen by -$74.07 million (-127.88%).
- KALV annual operating profit is now -7100.93% below its all-time high of -$1.83 million, reached on December 31, 2012.
Performance
KALV Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$45.81 M
-$1.60 M-3.61%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly operating income is -$45.81 million, with the most recent change of -$1.60 million (-3.61%) on October 31, 2024.
- Over the past year, KALV quarterly operating profit has dropped by -$5.81 million (-14.52%).
- KALV quarterly operating profit is now -4118.32% below its all-time high of -$1.09 million, reached on December 31, 2013.
Performance
KALV Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$163.18 M
-$16.07 M-10.92%
October 31, 2024
Summary
- As of February 8, 2025, KALV TTM operating income is -$163.18 million, with the most recent change of -$16.07 million (-10.92%) on October 31, 2024.
- Over the past year, KALV TTM operating profit has dropped by -$31.19 million (-23.63%).
- KALV TTM operating profit is now -14925.78% below its all-time high of -$1.09 million, reached on December 31, 2013.
Performance
KALV TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
KALV Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.8% | -14.5% | -23.6% |
| 3 y3 years | -127.9% | -94.1% | -121.1% |
| 5 y5 years | -342.6% | -393.2% | -280.9% |
KALV Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -127.9% | at low | -298.1% | at low | -100.7% | at low |
| 5 y | 5-year | -342.6% | at low | -411.4% | at low | -302.6% | at low |
| alltime | all time | -7100.9% | at low | -4118.3% | at low | <-9999.0% | at low |
KalVista Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$45.81 M(+3.6%) | -$163.18 M(+10.9%) |
| Jul 2024 | - | -$44.22 M(+10.5%) | -$147.12 M(+11.5%) |
| Apr 2024 | -$131.99 M(+38.8%) | -$40.00 M(+20.7%) | -$131.99 M(+22.3%) |
| Jan 2024 | - | -$33.15 M(+11.4%) | -$107.93 M(+6.1%) |
| Oct 2023 | - | -$29.75 M(+2.2%) | -$101.73 M(+3.9%) |
| Jul 2023 | - | -$29.09 M(+82.5%) | -$97.86 M(+2.9%) |
| Apr 2023 | -$95.09 M(+16.9%) | -$15.94 M(-40.8%) | -$95.09 M(+4.9%) |
| Jan 2023 | - | -$26.95 M(+4.1%) | -$90.65 M(+0.3%) |
| Oct 2022 | - | -$25.88 M(-1.6%) | -$90.39 M(+2.6%) |
| Jul 2022 | - | -$26.32 M(+128.7%) | -$88.11 M(+8.4%) |
| Apr 2022 | - | -$11.51 M(-56.9%) | -$81.31 M(-7.4%) |
| Apr 2022 | -$81.31 M(+40.4%) | - | - |
| Jan 2022 | - | -$26.68 M(+13.0%) | -$87.84 M(+19.0%) |
| Oct 2021 | - | -$23.60 M(+20.9%) | -$73.82 M(+17.2%) |
| Jul 2021 | - | -$19.52 M(+8.2%) | -$63.00 M(+8.8%) |
| Apr 2021 | -$57.92 M(+42.9%) | -$18.04 M(+42.5%) | -$57.92 M(+18.6%) |
| Jan 2021 | - | -$12.66 M(-1.0%) | -$48.84 M(-0.1%) |
| Oct 2020 | - | -$12.78 M(-11.5%) | -$48.91 M(+7.7%) |
| Jul 2020 | - | -$14.44 M(+61.2%) | -$45.41 M(+12.0%) |
| Apr 2020 | -$40.53 M(+35.9%) | -$8.96 M(-29.6%) | -$40.53 M(-5.4%) |
| Jan 2020 | - | -$12.72 M(+37.0%) | -$42.84 M(+16.5%) |
| Oct 2019 | - | -$9.29 M(-2.9%) | -$36.77 M(+13.6%) |
| Jul 2019 | - | -$9.56 M(-15.1%) | -$32.38 M(+8.6%) |
| Apr 2019 | -$29.82 M | -$11.26 M(+69.1%) | -$29.82 M(+38.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | -$6.66 M(+36.1%) | -$21.53 M(+12.0%) |
| Oct 2018 | - | -$4.89 M(-30.2%) | -$19.22 M(-5.2%) |
| Jul 2018 | - | -$7.01 M(+136.1%) | -$20.26 M(+8.3%) |
| Apr 2018 | -$18.70 M(-16.3%) | -$2.97 M(-31.7%) | -$18.70 M(-10.2%) |
| Jan 2018 | - | -$4.35 M(-26.8%) | -$20.82 M(-15.3%) |
| Oct 2017 | - | -$5.94 M(+8.9%) | -$24.59 M(+16.8%) |
| Jul 2017 | - | -$5.45 M(+7.2%) | -$21.06 M(+10.0%) |
| Apr 2017 | -$22.34 M(+47.2%) | -$5.09 M(-37.3%) | -$19.15 M(+0.1%) |
| Jan 2017 | - | -$8.12 M(+237.5%) | -$19.13 M(+15.4%) |
| Sep 2016 | - | -$2.40 M(-32.1%) | -$16.59 M(-13.1%) |
| Jun 2016 | - | -$3.54 M(-30.1%) | -$19.08 M(-10.0%) |
| Apr 2016 | -$15.18 M(-27.8%) | - | - |
| Mar 2016 | - | -$5.07 M(-9.0%) | -$21.20 M(+0.8%) |
| Dec 2015 | -$21.04 M(+160.1%) | -$5.57 M(+13.7%) | -$21.04 M(+9.1%) |
| Sep 2015 | - | -$4.90 M(-13.6%) | -$19.28 M(+7.4%) |
| Jun 2015 | - | -$5.67 M(+15.6%) | -$17.95 M(+21.9%) |
| Apr 2015 | -$8.09 M(-30.7%) | - | - |
| Mar 2015 | - | -$4.90 M(+28.4%) | -$14.72 M(+26.1%) |
| Dec 2014 | -$11.68 M(+123.9%) | -$3.82 M(+7.0%) | -$11.68 M(+30.5%) |
| Sep 2014 | - | -$3.57 M(+46.5%) | -$8.95 M(+66.3%) |
| Jun 2014 | - | -$2.44 M(+31.3%) | -$5.38 M(+82.8%) |
| Mar 2014 | - | -$1.86 M(+70.9%) | -$2.94 M(+170.9%) |
| Dec 2013 | -$5.22 M(+184.6%) | -$1.09 M | -$1.09 M |
| Dec 2012 | -$1.83 M | - | - |
FAQ
- What is KalVista Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual operating profit year-on-year change?
- What is KalVista Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly operating profit year-on-year change?
- What is KalVista Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals TTM operating profit year-on-year change?
What is KalVista Pharmaceuticals annual operating income?
The current annual operating profit of KALV is -$131.99 M
What is the all time high annual operating profit for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual operating income is -$1.83 M
What is KalVista Pharmaceuticals annual operating profit year-on-year change?
Over the past year, KALV annual operating income has changed by -$36.91 M (-38.81%)
What is KalVista Pharmaceuticals quarterly operating income?
The current quarterly operating profit of KALV is -$45.81 M
What is the all time high quarterly operating profit for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly operating income is -$1.09 M
What is KalVista Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, KALV quarterly operating income has changed by -$5.81 M (-14.52%)
What is KalVista Pharmaceuticals TTM operating income?
The current TTM operating profit of KALV is -$163.18 M
What is the all time high TTM operating profit for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM operating income is -$1.09 M
What is KalVista Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, KALV TTM operating income has changed by -$31.19 M (-23.63%)